To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RNF31andIRF9TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
591 representative clones for gene RNF31andIRF9 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BF058472 fibrotheoma, ovary RNF31andIRF9.a 1 to 540 540 to 1   tiling clone,   540/540
(100 %)
0 diff
(100 %id)
AI038835   RNF31andIRF9.a 122 to 547 426 to 1       426/426
(100 %)
3 diff
(99.3 %id)
DA212583 brain RNF31andIRF9.a 198 to 683 2 to 487   capped   486/486
(100 %)
0 diff
(100 %id)
DA531062 brain RNF31andIRF9.a 198 to 745 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
DB100190 testis RNF31andIRF9.a 233 to 809 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DA247881 brain RNF31andIRF9.a 249 to 821 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
CN287790 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells RNF31andIRF9.a 342 to 863 1 to 522   tiling clone,   522/522
(100 %)
1 diff
(99.9 %id)
DA232052 brain RNF31andIRF9.a 702 to 1268 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
NM_017999.4   RNF31andIRF9.a 772 to 4327 1 to 3556 exact RefSeq, AAA   3556/3556
(100 %)
0 diff
(100 %id)
DA312571 hippocampus RNF31andIRF9.a 773 to 1313 2 to 542   capped   541/541
(100 %)
1 diff
(99.9 %id)
DB088449 testis RNF31andIRF9.a 773 to 1307 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
DA311958 hippocampus RNF31andIRF9.a 792 to 1338 2 to 551   capped   550/550
(100 %)
5 diff
(99.1 %id)
DB145142 thymus RNF31andIRF9.a 792 to 1241 2 to 457   capped   456/456
(100 %)
10 diff
(97.9 %id)
DA315376 hippocampus RNF31andIRF9.a 793 to 1308 2 to 518   capped   517/517
(100 %)
1 diff
(99.9 %id)
DB071861 testis RNF31andIRF9.a 793 to 1334 2 to 545   capped   544/544
(100 %)
2 diff
(99.7 %id)
CB990090 Human Placenta, placenta RNF31andIRF9.a 797 to 1367 28 to 599       572/834
(68 %)
27 diff
(96.8 %id)
CF994043 Human Placenta, placenta RNF31andIRF9.a 797 to 1493 28 to 717       690/721
(95 %)
15 diff
(98.0 %id)
DB285125 uterus RNF31andIRF9.a 803 to 1130 2 to 329   capped   328/328
(100 %)
0 diff
(100 %id)
DA116678 cerebellum RNF31andIRF9.a 814 to 1403 2 to 592   capped   591/591
(100 %)
2 diff
(99.7 %id)
DA337050 hippocampus RNF31andIRF9.a 814 to 1386 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DB154823 thymus RNF31andIRF9.a 814 to 1382 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DB194538 trachea RNF31andIRF9.a 815 to 1345 2 to 533   capped   532/532
(100 %)
2 diff
(99.7 %id)
BI459554 testis RNF31andIRF9.a 817 to 1575 1 to 774       771/881
(87 %)
32 diff
(96.4 %id)
AK291247   RNF31andIRF9.a 820 to 4324 1 to 3505 exact     3505/3505
(100 %)
1 diff
(100.0 %id)
DA499540 brain RNF31andIRF9.a 820 to 1384 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DA788474 brain RNF31andIRF9.a 820 to 1339 2 to 521   capped   520/520
(100 %)
3 diff
(99.5 %id)
DB130692 thymus RNF31andIRF9.a 820 to 1060 2 to 242   capped   241/241
(100 %)
0 diff
(100 %id)
DA440872 tongue, tumor tissue RNF31andIRF9.a 821 to 1343 2 to 528   capped   527/527
(100 %)
6 diff
(98.9 %id)
DA462249 tongue, tumor tissue RNF31andIRF9.a 821 to 1236 2 to 417   capped   416/416
(100 %)
1 diff
(99.8 %id)
DA757051   RNF31andIRF9.a 821 to 1376 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DA960940 Spleen RNF31andIRF9.a 821 to 1128 2 to 309   capped   308/308
(100 %)
0 diff
(100 %id)
BM151690 leukopheresis RNF31andIRF9.a 821 to 1236 1 to 416       416/417
(99 %)
15 diff
(96.5 %id)
DB067405 testis RNF31andIRF9.a 821 to 1289 2 to 470   capped   469/469
(100 %)
4 diff
(99.2 %id)
DB125428 thymus RNF31andIRF9.a 821 to 1400 2 to 581   capped   580/581
(99 %)
2 diff
(99.7 %id)
AK225832 brain RNF31andIRF9.a 822 to 4320 1 to 3499 A539V AAA   3499/3499
(100 %)
1 diff
(100.0 %id)
DA117776 cerebellum RNF31andIRF9.a 822 to 1386 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA218836 brain RNF31andIRF9.a 822 to 1454 2 to 635   capped   634/634
(100 %)
1 diff
(99.9 %id)
DA227327 brain RNF31andIRF9.a 822 to 1388 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DB146597 thymus RNF31andIRF9.a 822 to 1309 2 to 490   capped   489/489
(100 %)
3 diff
(99.4 %id)
DA172571 amygdala RNF31andIRF9.a 823 to 1073 2 to 254   capped   253/253
(100 %)
3 diff
(98.9 %id)
DA231881 brain RNF31andIRF9.a 823 to 1377 2 to 556   capped   555/555
(100 %)
2 diff
(99.7 %id)
DA242556 brain RNF31andIRF9.a 823 to 1399 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DA312546 hippocampus RNF31andIRF9.a 823 to 1360 2 to 539   capped   538/547
(98 %)
3 diff
(99.5 %id)
DA331195 hippocampus RNF31andIRF9.a 823 to 1413 2 to 593   capped   592/592
(100 %)
1 diff
(99.9 %id)
DA339553 hippocampus RNF31andIRF9.a 823 to 1401 2 to 581   capped   580/580
(100 %)
2 diff
(99.7 %id)
DA788816 brain RNF31andIRF9.a 823 to 1084 2 to 263   capped   262/264
(99 %)
3 diff
(98.9 %id)
DA814821   RNF31andIRF9.a 823 to 1360 2 to 539   capped   538/546
(98 %)
2 diff
(99.7 %id)
DB064271 testis RNF31andIRF9.a 823 to 1226 2 to 405   capped   404/404
(100 %)
1 diff
(99.8 %id)
DB129332 thymus RNF31andIRF9.a 823 to 1371 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
DB132245 thymus RNF31andIRF9.a 823 to 1336 2 to 516   capped   515/515
(100 %)
5 diff
(99.1 %id)
DB159575 thymus RNF31andIRF9.a 823 to 1398 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
DB165734 thymus RNF31andIRF9.a 823 to 1372 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DB217897 trachea RNF31andIRF9.a 823 to 1290 2 to 469   capped   468/468
(100 %)
0 diff
(100 %id)
DB269468 uterus RNF31andIRF9.a 823 to 1385 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
DA993804 synovial membrane tissue from rheumatioidarthritis RNF31andIRF9.a 824 to 1202 2 to 381   capped   380/385
(98 %)
4 diff
(99.0 %id)
DB082045 testis RNF31andIRF9.a 824 to 1229 2 to 407   capped   406/406
(100 %)
1 diff
(99.8 %id)
DA108520 cerebellum RNF31andIRF9.a 826 to 1376 2 to 554   capped   553/553
(100 %)
2 diff
(99.7 %id)
DA123504 cerebellum RNF31andIRF9.a 826 to 1018 2 to 194   capped   193/193
(100 %)
0 diff
(100 %id)
DA195886 amygdala RNF31andIRF9.a 826 to 1395 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
DA221235 brain RNF31andIRF9.a 826 to 1416 2 to 593   capped   592/592
(100 %)
2 diff
(99.7 %id)
DA437784 tongue, tumor tissue RNF31andIRF9.a 827 to 1411 2 to 588   capped   587/587
(100 %)
4 diff
(99.4 %id)
DB727691 testis RNF31andIRF9.a 827 to 1369 1 to 545       545/675
(80 %)
10 diff
(98.6 %id)
DB240703 trachea RNF31andIRF9.a 827 to 1411 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
DA290852 hippocampus RNF31andIRF9.a 828 to 1399 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
BI906039 leukocyte RNF31andIRF9.a 828 to 1121 22 to 313       292/313
(93 %)
16 diff
(94.9 %id)
TI_57231471   RNF31andIRF9.a 828 to 1602 22 to 814       791/814
(97 %)
46 diff
(94.4 %id)
DA770132 brain RNF31andIRF9.a 828 to 1394 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DA446800 tongue, tumor tissue RNF31andIRF9.a 830 to 1404 2 to 578   capped   577/577
(100 %)
5 diff
(99.2 %id)
CO246431 Chondrosarcoma Lung Metastasis cell lines, lung RNF31andIRF9.a 830 to 1336 8 to 516       509/753
(67 %)
42 diff
(94.5 %id)
DA222952 brain RNF31andIRF9.a 831 to 1358 2 to 529   capped   528/528
(100 %)
0 diff
(100 %id)
BX362939   RNF31andIRF9.a 831 to 1815 1 to 975       975/984
(99 %)
15 diff
(98.5 %id)
DB140502 thymus RNF31andIRF9.a 831 to 1339 2 to 510   capped   509/509
(100 %)
1 diff
(99.9 %id)
DB153610 thymus RNF31andIRF9.a 831 to 1400 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
CB995980 placenta, pre-eclamptic placenta RNF31andIRF9.a 832 to 1328 28 to 530       503/962
(52 %)
13 diff
(98.7 %id)
CB992109 placenta, pre-eclamptic placenta RNF31andIRF9.a 832 to 1440 28 to 643       616/888
(69 %)
24 diff
(97.3 %id)
CB996237 placenta, pre-eclamptic placenta RNF31andIRF9.a 832 to 1517 28 to 720       693/848
(81 %)
37 diff
(95.7 %id)
DA099590 cerebellum RNF31andIRF9.a 833 to 1382 2 to 554   capped   553/553
(100 %)
3 diff
(99.5 %id)
DA247184 brain RNF31andIRF9.a 833 to 1430 2 to 599   capped   598/598
(100 %)
4 diff
(99.4 %id)
DA247584 brain RNF31andIRF9.a 833 to 1405 2 to 574   capped   573/573
(100 %)
3 diff
(99.5 %id)
DA314931 hippocampus RNF31andIRF9.a 833 to 1193 2 to 362   capped   361/361
(100 %)
0 diff
(100 %id)
DA397978 thalamus RNF31andIRF9.a 833 to 1426 2 to 596   capped   595/595
(100 %)
3 diff
(99.5 %id)
DA990267 synovial membrane tissue from rheumatioidarthritis RNF31andIRF9.a 833 to 1358 2 to 527   capped   526/526
(100 %)
0 diff
(100 %id)
DB072756 testis RNF31andIRF9.a 833 to 1268 2 to 439   capped   438/438
(100 %)
3 diff
(99.4 %id)
DB085377 testis RNF31andIRF9.a 833 to 1376 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DB284863 uterus RNF31andIRF9.a 836 to 1360 2 to 527   capped   526/532
(98 %)
4 diff
(99.3 %id)
BG390974 embryonal carcinoma, cell line, testis RNF31andIRF9.a 839 to 1585 1 to 755       755/802
(94 %)
12 diff
(98.6 %id)
DB289230 uterus RNF31andIRF9.a 839 to 1403 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
CN344564 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells RNF31andIRF9.a 845 to 1417 1 to 573       573/573
(100 %)
6 diff
(99.0 %id)
BX401409   RNF31andIRF9.a 847 to 1243 1 to 401       401/946
(42 %)
6 diff
(99.4 %id)
DB099268 testis RNF31andIRF9.a 847 to 1358 2 to 513   capped   512/512
(100 %)
0 diff
(100 %id)
DA661192   RNF31andIRF9.a 850 to 1410 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
BG480392 choriocarcinoma, placenta RNF31andIRF9.a 851 to 1568 1 to 713       713/717
(99 %)
23 diff
(96.8 %id)
BG774364 choriocarcinoma, placenta RNF31andIRF9.a 851 to 1615 1 to 773       773/773
(100 %)
16 diff
(98.0 %id)
BC012077 Placenta, choriocarcinoma RNF31andIRF9.a 852 to 4323 1 to 3472 exact tiling clone, available from MGC, AAA   3472/3472
(100 %)
0 diff
(100 %id)
DA184507 amygdala RNF31andIRF9.a 852 to 1339 2 to 491   capped   490/490
(100 %)
3 diff
(99.4 %id)
DA990262 synovial membrane tissue from rheumatioidarthritis RNF31andIRF9.a 852 to 1358 2 to 509   capped   508/508
(100 %)
2 diff
(99.7 %id)
BQ428266 leiomyosarcoma, uterus RNF31andIRF9.a 854 to 1442 36 to 625       590/879
(67 %)
21 diff
(97.7 %id)
CN344566 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 RNF31andIRF9.a 862 to 1192 1 to 331       331/331
(100 %)
2 diff
(99.4 %id)
CN344565 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells RNF31andIRF9.a 867 to 1317 1 to 451       451/451
(100 %)
1 diff
(99.8 %id)
DN997309 breast cancer, Mammary gland (cancer tissue) RNF31andIRF9.a 884 to 1470 9 to 595       587/595
(98 %)
6 diff
(99.0 %id)
CN344568 embryonic stem cells, cell lines H1, H7, andH9 RNF31andIRF9.a 891 to 1543 1 to 653       653/653
(100 %)
2 diff
(99.7 %id)
BX346805 Neuroblastoma Cot 25-normalized RNF31andIRF9.a 892 to 1657 1 to 758       758/817
(92 %)
39 diff
(95.3 %id)
TI_57237594   RNF31andIRF9.a 911 to 1572 117 to 806       690/1085
(63 %)
40 diff
(96.4 %id)
BM838560 Ascites, stomach RNF31andIRF9.a 919 to 1224 1 to 306       306/306
(100 %)
2 diff
(99.4 %id)
BP342162 stomach mucosa RNF31andIRF9.a 957 to 1540 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
AB265810   RNF31andIRF9.a 1021 to 4239 1 to 3219 exact     3219/3219
(100 %)
0 diff
(100 %id)
EL733508 mixed RNF31andIRF9.a 1021 to 1677 1 to 655       656/655
(100 %)
4 diff
(99.4 %id)
BM805861 brain, hippocampus RNF31andIRF9.a 1061 to 1969 20 to 940       921/1128
(81 %)
39 diff
(96.6 %id)
BX374897 Neuroblastoma Cot 25-normalized RNF31andIRF9.a 1158 to 1824 1 to 668       668/668
(100 %)
17 diff
(97.5 %id)
DA433520 tongue, tumor tissue RNF31andIRF9.a 1320 to 2038 2 to 728   capped   727/742
(97 %)
8 diff
(99.0 %id)
BE886242 leiomyosarcoma, uterus RNF31andIRF9.a 1357 to 2096 1 to 734       734/736
(99 %)
22 diff
(97.1 %id)
BF792645 adrenal cortex carcinoma, cell line, adrenal gland RNF31andIRF9.a 1373 to 2011 1 to 639       639/639
(100 %)
4 diff
(99.4 %id)
BE778774 eye, retinoblastoma RNF31andIRF9.a 1414 to 2094 1 to 679       679/814
(83 %)
39 diff
(95.3 %id)
BX347033   RNF31andIRF9.a 1431 to 2214 1 to 777       777/877
(88 %)
65 diff
(92.6 %id)
BM556679 amelanotic melanoma, cell line, skin RNF31andIRF9.a 1480 to 2444 28 to 1003       976/1047
(93 %)
29 diff
(97.3 %id)
BM915302 amelanotic melanoma, cell line, skin RNF31andIRF9.a 1480 to 2344 20 to 892       873/1060
(82 %)
21 diff
(98.1 %id)
BM553042 amelanotic melanoma, cell line, skin RNF31andIRF9.a 1481 to 2492 1 to 1023       1023/1128
(90 %)
24 diff
(97.9 %id)
BM811285 amelanotic melanoma, cell line, skin RNF31andIRF9.a 1482 to 2434 1 to 973       973/1044
(93 %)
50 diff
(95.3 %id)
BM807974 amelanotic melanoma, cell line, skin RNF31andIRF9.a 1482 to 2343 1 to 866       866/936
(92 %)
9 diff
(99.1 %id)
AK055542   RNF31andIRF9.a 1975 to 4324 1 to 2350   available from FLJ,   2350/2350
(100 %)
1 diff
(100.0 %id)
DA573489   RNF31andIRF9.a 1976 to 2514 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
CD369288 Alveolar Macrophage, lung RNF31andIRF9.a 3628 to 4320 710 to 19   AAA   692/699
(98 %)
1 diff
(99.9 %id)
CB305470 lung, Primary Lung Cystic Fibrosis EpithelialCells RNF31andIRF9.a 3634 to 4320 705 to 19   AAA   687/687
(100 %)
2 diff
(99.8 %id)
DB510908 testis RNF31andIRF9.a 3639 to 4327 1 to 687     Submitted on the opposite strand 687/687
(100 %)
11 diff
(98.4 %id)
CD742923 Alveolar Macrophage, lung RNF31andIRF9.a 3659 to 4327 683 to 16   AAA   668/668
(100 %)
1 diff
(99.9 %id)
BU736973 eye, lens RNF31andIRF9.a 3663 to 4320 676 to 19   AAA   658/658
(100 %)
0 diff
(100 %id)
BX329423 Neuroblastoma Cot 25-normalized RNF31andIRF9.a 3703 to 4317 616 to 1       616/642
(95 %)
27 diff
(95.8 %id)
BF115796 carcinoid, lung RNF31andIRF9.a 3738 to 4227 7 to 496     Submitted on the opposite strand 490/496
(98 %)
0 diff
(100 %id)
AA196477.
matches multiple genes
muscle, skeletal muscle RNF31andIRF9.a 3740 to 4320 1 to 576     also hits gene OPTN 576/576
(100 %)
13 diff
(97.8 %id)
BM128803 Islets of Langerhans, Pancreas RNF31andIRF9.a 3748 to 4326 580 to 2       579/580
(99 %)
2 diff
(99.7 %id)
BP213062 cerebrum RNF31andIRF9.a 3752 to 4322 1 to 571       571/571
(100 %)
0 diff
(100 %id)
CK819438 Islets of Langerhans, Pancreas RNF31andIRF9.a 3756 to 4326 572 to 2       571/572
(99 %)
0 diff
(100 %id)
DB313102 tongue, tumor tissue RNF31andIRF9.a 3763 to 4320 558 to 1       558/558
(100 %)
0 diff
(100 %id)
DB318919   RNF31andIRF9.a 3784 to 4324 541 to 1       541/541
(100 %)
0 diff
(100 %id)
AI828982 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) RNF31andIRF9.a 3821 to 4323 503 to 1       503/503
(100 %)
0 diff
(100 %id)
BF516479   RNF31andIRF9.a 3823 to 4324 519 to 18   AAA   502/502
(100 %)
0 diff
(100 %id)
BP397181 pancreatic islet RNF31andIRF9.a 3827 to 4320 1 to 495     Submitted on the opposite strand 495/495
(100 %)
1 diff
(99.8 %id)
AI126606   RNF31andIRF9.a 3831 to 4321 498 to 8       491/498
(98 %)
1 diff
(99.8 %id)
BM983142 lung, Primary Lung Cystic Fibrosis EpithelialCells RNF31andIRF9.a 3835 to 4320 504 to 19   AAA   486/486
(100 %)
0 diff
(100 %id)
AI932237 anaplastic oligodendroglioma, brain RNF31andIRF9.a 3864 to 4321 460 to 3       458/460
(99 %)
0 diff
(100 %id)
BF513500   RNF31andIRF9.a 3865 to 4324 477 to 18   AAA   460/460
(100 %)
1 diff
(99.8 %id)
AI346355 adenocarcinoma, colon RNF31andIRF9.a 3866 to 4327 475 to 13   AAA   463/463
(100 %)
7 diff
(98.5 %id)
AA530897 normal prostate, Prostate RNF31andIRF9.a 3867 to 4321 456 to 2       455/496
(91 %)
15 diff
(97.0 %id)
CN397954 embryonic stem cells, cell lines H1, H7, andH9 RNF31andIRF9.a 3877 to 4448 1 to 572   tiling clone,   572/572
(100 %)
1 diff
(99.9 %id)
AA454999 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus RNF31andIRF9.a 3885 to 4326 1 to 439   fully sequenced,   439/439
(100 %)
7 diff
(98.5 %id)
BX099826 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus RNF31andIRF9.a 3890 to 4326 1 to 437   AAA   437/437
(100 %)
0 diff
(100 %id)
AI392791 B-cell, chronic lymphotic leukemia RNF31andIRF9.a 3890 to 4325 437 to 2       436/437
(99 %)
0 diff
(100 %id)
AI500250 anaplastic oligodendroglioma, brain RNF31andIRF9.a 3890 to 4321 434 to 3       432/434
(99 %)
0 diff
(100 %id)
BM150813 leukopheresis RNF31andIRF9.a 3903 to 4324 438 to 17   AAA   422/422
(100 %)
4 diff
(99.1 %id)
AW301125 colon, moderately differentiated adenocarcinoma RNF31andIRF9.a 3917 to 4324 427 to 20   AAA   408/408
(100 %)
1 diff
(99.8 %id)
BG058600 blood, lymphocyte RNF31andIRF9.a 3919 to 4326 408 to 1       408/408
(100 %)
0 diff
(100 %id)
F31272 pectoral muscle (after mastectomy) RNF31andIRF9.a 3921 to 4247 1 to 326       326/326
(100 %)
5 diff
(98.5 %id)
AI379512 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus RNF31andIRF9.a 3923 to 4321 407 to 9       399/407
(98 %)
1 diff
(99.8 %id)
AA627430 colon, colon tumor RER+ RNF31andIRF9.a 3924 to 4321 399 to 3       397/399
(99 %)
3 diff
(99.3 %id)
AA969584 pooled RNF31andIRF9.a 3932 to 4321 392 to 4       389/392
(99 %)
6 diff
(98.5 %id)
AI344934 invasive adenocarcinoma, lung RNF31andIRF9.a 3940 to 4283 34 to 377     Submitted on the opposite strand 344/377
(91 %)
6 diff
(98.5 %id)
AI340579 bone marrow, stem cell 34+/38+ RNF31andIRF9.a 3940 to 4320 11 to 391   AAA Submitted on the opposite strand 381/391
(97 %)
7 diff
(98.3 %id)
AI583909 bone marrow, CD34+, T negative, patient with chronicmyelogenous leukemia RNF31andIRF9.a 3940 to 4324 11 to 395   AAA Submitted on the opposite strand 385/395
(97 %)
7 diff
(98.3 %id)
F27503 pectoral muscle (after mastectomy) RNF31andIRF9.a 3942 to 4326 10 to 395       386/401
(96 %)
8 diff
(98.1 %id)
AI872365 serous papillary carcinoma, high grade, 2pooled tumors, uterus RNF31andIRF9.a 3943 to 4319 377 to 1       377/377
(100 %)
0 diff
(100 %id)
AW089759 ovary, tumor, 5 pooled (see description) RNF31andIRF9.a 3948 to 4326 379 to 1       379/379
(100 %)
2 diff
(99.5 %id)
F37079 pectoral muscle (after mastectomy) RNF31andIRF9.a 3950 to 4276 1 to 327       327/327
(100 %)
1 diff
(99.7 %id)
AJ573816 pectoral muscle (after mastectomy) RNF31andIRF9.a 3954 to 4320 10 to 376       367/376
(97 %)
6 diff
(98.5 %id)
AI825967 poorly differentiated adenocarcinoma withsignet ring cell features, stomach RNF31andIRF9.a 3954 to 4320 367 to 1       367/367
(100 %)
0 diff
(100 %id)
AA883821 pooled RNF31andIRF9.a 3961 to 4321 366 to 8       359/366
(98 %)
4 diff
(99.0 %id)
BE243795 leukopheresis RNF31andIRF9.a 3994 to 4322 331 to 3       329/331
(99 %)
0 diff
(100 %id)
AA877717 colon, colon tumor RER+ RNF31andIRF9.a 4017 to 4321 309 to 7       303/344
(88 %)
2 diff
(99.5 %id)
AA455000 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus RNF31andIRF9.a 4024 to 4326 303 to 1   fully sequenced,   303/303
(100 %)
5 diff
(98.4 %id)
AI766771 2 pooled tumors (clear cell type), Kidney RNF31andIRF9.a 4035 to 4323 297 to 9       289/300
(96 %)
0 diff
(100 %id)
BF924380 nervous_tumor RNF31andIRF9.a 4054 to 4292 239 to 1     Submitted on the opposite strand 239/248
(96 %)
4 diff
(98.4 %id)
AA872684 pooled germ cell tumors RNF31andIRF9.a 4087 to 4326 238 to 1       238/238
(100 %)
5 diff
(97.9 %id)
AI991913 anaplastic oligodendroglioma, brain RNF31andIRF9.a 4123 to 4326 225 to 20   AAA   206/206
(100 %)
5 diff
(97.6 %id)
AI202023 anaplastic oligodendroglioma, brain RNF31andIRF9.a 4130 to 4324 217 to 23       195/217
(89 %)
1 diff
(99.6 %id)
AI024031 liver and spleen RNF31andIRF9.a 4139 to 4321 186 to 4       183/186
(98 %)
0 diff
(100 %id)
AI625173 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors RNF31andIRF9.a 4143 to 4325 184 to 3       182/184
(98 %)
0 diff
(100 %id)
AW303193 invasive adenocarcinoma, lung RNF31andIRF9.a 4172 to 4324 1 to 154   AAA Submitted on the opposite strand 154/154
(100 %)
9 diff
(94.2 %id)
BE042120 borderline ovarian carcinoma, ovary RNF31andIRF9.a 4172 to 4319 18 to 166       149/182
(81 %)
6 diff
(96.8 %id)
BE043198 borderline ovarian carcinoma, ovary RNF31andIRF9.a 4172 to 4321 18 to 168       151/183
(82 %)
6 diff
(96.8 %id)
BE043513 borderline ovarian carcinoma, ovary RNF31andIRF9.a 4172 to 4319 18 to 166       149/179
(83 %)
6 diff
(96.7 %id)
BE043718 borderline ovarian carcinoma, ovary RNF31andIRF9.a 4172 to 4324 18 to 171   AAA   154/171
(90 %)
6 diff
(96.5 %id)
BE041273 borderline ovarian carcinoma, ovary RNF31andIRF9.a 4172 to 4321 18 to 168       151/184
(82 %)
6 diff
(96.8 %id)
BF055651 brain, oligodendroglioma RNF31andIRF9.a 4172 to 4319 18 to 166       149/179
(83 %)
6 diff
(96.7 %id)
AW268922 invasive adenocarcinoma, lung RNF31andIRF9.a 4173 to 4325 1 to 154     Submitted on the opposite strand 154/155
(99 %)
6 diff
(96.2 %id)
BE857803 ovary, papillary serous carcinoma RNF31andIRF9.a 4173 to 4320 1 to 149   AAA   149/149
(100 %)
9 diff
(94.0 %id)
BE857804 ovary, papillary serous carcinoma RNF31andIRF9.a 4173 to 4320 1 to 149   AAA   149/149
(100 %)
9 diff
(94.0 %id)
BI024657 marrow RNF31andIRF9.a 4174 to 4314 1 to 140       140/140
(100 %)
9 diff
(93.6 %id)
AI313345 bone marrow, stem cell 34+/38+ RNF31andIRF9.a 4176 to 4319 1 to 145   AAA Submitted on the opposite strand 145/145
(100 %)
7 diff
(95.2 %id)
AI053703 ovary, papillary serous carcinoma RNF31andIRF9.a 4180 to 4317 160 to 22       139/165
(84 %)
0 diff
(100 %id)
AI054290 ovary, papillary serous carcinoma RNF31andIRF9.a 4180 to 4324 163 to 18   AAA   146/151
(96 %)
10 diff
(93.4 %id)
FN156540 breast carcinoma RNF31andIRF9.a 4181 to 4289 1 to 113       113/113
(100 %)
5 diff
(95.6 %id)
AI307077 borderline ovarian carcinoma, ovary RNF31andIRF9.a 4183 to 4325 1 to 143     Submitted on the opposite strand 143/160
(89 %)
5 diff
(96.9 %id)
AI312974 bone marrow, stem cell 34+/38+ RNF31andIRF9.a 4183 to 4324 1 to 142   AAA Submitted on the opposite strand 142/142
(100 %)
4 diff
(97.2 %id)
AI349666 adenocarcinoma, breast RNF31andIRF9.a 4183 to 4321 1 to 139     Submitted on the opposite strand 139/163
(85 %)
4 diff
(97.6 %id)
AW072881 bone marrow, stem cell 34+/38+ RNF31andIRF9.a 4183 to 4318 1 to 136     Submitted on the opposite strand 136/136
(100 %)
4 diff
(97.1 %id)
AW073020 bone marrow, stem cell 34+/38+ RNF31andIRF9.a 4183 to 4318 1 to 136     Submitted on the opposite strand 136/136
(100 %)
4 diff
(97.1 %id)
AW073028 bone marrow, stem cell 34+/38+ RNF31andIRF9.a 4183 to 4318 1 to 136     Submitted on the opposite strand 136/136
(100 %)
4 diff
(97.1 %id)
AW073021 bone marrow, stem cell 34+/38+ RNF31andIRF9.a 4183 to 4318 1 to 136     Submitted on the opposite strand 136/136
(100 %)
4 diff
(97.1 %id)
AW071274 bone marrow, stem cell 34+/38+ RNF31andIRF9.a 4183 to 4318 1 to 136     Submitted on the opposite strand 136/136
(100 %)
4 diff
(97.1 %id)
AW074823 bone marrow, stem cell 34+/38+ RNF31andIRF9.a 4183 to 4321 1 to 139     Submitted on the opposite strand 139/139
(100 %)
4 diff
(97.2 %id)
BE139161 ovary, papillary serous carcinoma RNF31andIRF9.a 4183 to 4320 1 to 138     Submitted on the opposite strand 138/138
(100 %)
5 diff
(96.4 %id)
BE138637 invasive adenocarcinoma, lung RNF31andIRF9.a 4183 to 4318 1 to 136     Submitted on the opposite strand 136/138
(98 %)
4 diff
(97.2 %id)
AW301782 invasive adenocarcinoma, lung RNF31andIRF9.a 4183 to 4312 1 to 130     Submitted on the opposite strand 130/130
(100 %)
5 diff
(96.2 %id)
AW302889 invasive adenocarcinoma, lung RNF31andIRF9.a 4183 to 4312 1 to 130     Submitted on the opposite strand 130/130
(100 %)
4 diff
(97.0 %id)
AW303014 invasive adenocarcinoma, lung RNF31andIRF9.a 4183 to 4315 1 to 133     Submitted on the opposite strand 133/133
(100 %)
4 diff
(97.0 %id)
AW301345 invasive adenocarcinoma, lung RNF31andIRF9.a 4183 to 4322 1 to 140     Submitted on the opposite strand 140/141
(99 %)
4 diff
(97.2 %id)
BE043525 borderline ovarian carcinoma, ovary RNF31andIRF9.a 4191 to 4321 1 to 131       131/143
(91 %)
4 diff
(97.3 %id)
BF718389 epidermis, skin RNF31andIRF9.a 4201 to 4319 119 to 1       119/119
(100 %)
2 diff
(98.4 %id)
BF718672 epidermis, foreskin RNF31andIRF9.a 4201 to 4320 124 to 5       120/124
(96 %)
0 diff
(100 %id)
EC512601 Prostate RNF31andIRF9.a 4214 to 4318 1 to 106       106/108
(98 %)
5 diff
(95.4 %id)
AI307471 bone marrow, stem cell 34+/38+ RNF31andIRF9.a 4222 to 4325 1 to 104     Submitted on the opposite strand 104/128
(81 %)
1 diff
(99.3 %id)
AA974114 pooled germ cell tumors RNF31andIRF9.a 4226 to 4326 101 to 1       101/101
(100 %)
0 diff
(100 %id)
DA397308 thalamus RNF31andIRF9.b 1 to 577 2 to 578   tiling clone, capped   577/577
(100 %)
0 diff
(100 %id)
AK122711 tongue, tumor tissue RNF31andIRF9.b 366 to 3199 1 to 2834   tiling clone, available from FLJ,   2834/2834
(100 %)
1 diff
(100.0 %id)
AY256461   RNF31andIRF9.c 1 to 3196 1 to 3196 P378S tiling clone, AAA   3196/3196
(100 %)
1 diff
(100.0 %id)
DB132393 thymus RNF31andIRF9.c 360 to 889 2 to 531   capped   530/530
(100 %)
0 diff
(100 %id)
BQ901188 epidermoid carcinoma, cell line, lung RNF31andIRF9.c 388 to 1181 1 to 798       798/908
(87 %)
12 diff
(98.7 %id)
BQ939991 leiomyosarcoma, uterus RNF31andIRF9.c 388 to 1207 28 to 850       823/854
(96 %)
18 diff
(97.9 %id)
DB135336 thymus RNF31andIRF9.c 399 to 880 2 to 483   capped   482/482
(100 %)
0 diff
(100 %id)
DB154276 thymus RNF31andIRF9.c 403 to 952 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
CD359323 testis RNF31andIRF9.c 422 to 1264 1 to 854       854/871
(98 %)
24 diff
(97.3 %id)
BE730128 melanotic melanoma, skin RNF31andIRF9.c 430 to 1183 29 to 775       747/1043
(71 %)
21 diff
(98.0 %id)
BE410955 choriocarcinoma, placenta RNF31andIRF9.c 449 to 1123 17 to 687       671/688
(97 %)
13 diff
(98.2 %id)
BE727468 melanotic melanoma, skin RNF31andIRF9.c 453 to 1190 1 to 726       726/836
(86 %)
16 diff
(98.1 %id)
BF025806 melanotic melanoma, skin RNF31andIRF9.c 454 to 1125 1 to 661       661/665
(99 %)
17 diff
(97.5 %id)
BM018020 astrocytoma grade IV, cell line, brain RNF31andIRF9.c 502 to 1089 1 to 604       604/1282
(47 %)
35 diff
(97.3 %id)
BM018054 astrocytoma grade IV, cell line, brain RNF31andIRF9.c 503 to 1089 2 to 595       594/626
(94 %)
21 diff
(96.7 %id)
TI_59388601   RNF31andIRF9.c 503 to 1089 100 to 702       603/1281
(47 %)
34 diff
(97.4 %id)
TI_59388636   RNF31andIRF9.c 503 to 1089 71 to 664       594/625
(95 %)
16 diff
(97.5 %id)
DA488210 brain RNF31andIRF9.c 557 to 1105 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
BU522057 leiomyosarcoma, uterus RNF31andIRF9.c 590 to 1229 1 to 643       643/782
(82 %)
5 diff
(99.4 %id)
BX644892   RNF31andIRF9.c 671 to 1043 1 to 373       373/373
(100 %)
0 diff
(100 %id)
BU430135 lymph RNF31andIRF9.c 825 to 1240 8 to 423       416/423
(98 %)
7 diff
(98.4 %id)
TI_154151404   RNF31andIRF9.c 825 to 1354 80 to 610       531/535
(99 %)
10 diff
(98.2 %id)
BE894044 melanotic melanoma, skin RNF31andIRF9.c 902 to 1287 1 to 394       394/1016
(38 %)
16 diff
(98.5 %id)
DA921345 small intestine RNF31andIRF9.c 975 to 1520 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
BX459480 brain, fetal brain RNF31andIRF9.c 985 to 1831 1 to 845       845/915
(92 %)
24 diff
(97.4 %id)
DA584120 lung RNF31andIRF9.c 1010 to 1594 2 to 586   capped   585/585
(100 %)
2 diff
(99.7 %id)
DA059025 cerebellum RNF31andIRF9.c 1012 to 1566 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
BX459481 brain, fetal brain RNF31andIRF9.c 1045 to 2013 1 to 961       961/961
(100 %)
9 diff
(99.1 %id)
BQ934470 sciatic nerve RNF31andIRF9.c 1093 to 1928 1 to 845       845/940
(89 %)
15 diff
(98.5 %id)
CD300057 testis RNF31andIRF9.c 1138 to 1986 28 to 883       856/884
(96 %)
19 diff
(97.9 %id)
DA849076 placenta RNF31andIRF9.c 1139 to 1683 2 to 546   capped   545/545
(100 %)
2 diff
(99.7 %id)
BM785592 Ascites, stomach RNF31andIRF9.c 1193 to 1804 1 to 612       612/612
(100 %)
1 diff
(99.9 %id)
BC009821 Ovary, adenocarcinoma RNF31andIRF9.c 1291 to 3193 1 to 1903   tiling clone, available from MGC, AAA   1903/1903
(100 %)
0 diff
(100 %id)
CR988368 T-Lymphocytes RNF31andIRF9.c 1291 to 1856 1 to 572       572/577
(99 %)
11 diff
(98.1 %id)
CN344567 embryonic stem cells, DMSO-treated H9 cellline RNF31andIRF9.c 1300 to 1814 1 to 515       515/515
(100 %)
1 diff
(99.9 %id)
BC017376 Ovary, adenocarcinoma RNF31andIRF9.c 1301 to 3193 1 to 1893   available from MGC, AAA   1893/1893
(100 %)
0 diff
(100 %id)
BU784118 insulinoma, Pancreas RNF31andIRF9.c 1305 to 1896 1 to 592       592/592
(100 %)
4 diff
(99.4 %id)
BE741434 adenocarcinoma cell line, ovary RNF31andIRF9.c 1312 to 2023 1 to 729   available from MGC,   680/796
(85 %)
33 diff
(95.9 %id)
BE743235 adenocarcinoma cell line, ovary RNF31andIRF9.c 1321 to 2001 1 to 698   available from MGC,   698/728
(95 %)
33 diff
(95.5 %id)
TI_1948139364   RNF31andIRF9.c 1335 to 2023 114 to 804       691/1340
(51 %)
16 diff
(98.9 %id)
BM562195 leukocyte RNF31andIRF9.c 1342 to 2194 43 to 900       858/1131
(75 %)
37 diff
(96.8 %id)
CV028138 mixed RNF31andIRF9.c 1343 to 1974 1 to 633       633/633
(100 %)
4 diff
(99.4 %id)
TI_1948140120   RNF31andIRF9.c 1343 to 2030 125 to 819       695/1370
(50 %)
23 diff
(98.4 %id)
DA382461 thalamus RNF31andIRF9.c 1346 to 1916 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
BX429313 brain, fetal brain RNF31andIRF9.c 1354 to 2021 1 to 668       668/841
(79 %)
25 diff
(97.1 %id)
BQ926737 large cell carcinoma, lung RNF31andIRF9.c 1357 to 2135 1 to 785       785/950
(82 %)
27 diff
(97.2 %id)
CD621825   RNF31andIRF9.c 1386 to 1970 600 to 16       585/606
(96 %)
0 diff
(100 %id)
CD621826   RNF31andIRF9.c 1386 to 1970 7 to 591       585/607
(96 %)
2 diff
(99.7 %id)
CD672946 eye, Iris RNF31andIRF9.c 1424 to 1888 1 to 464       464/464
(100 %)
1 diff
(99.8 %id)
BG996899 head_neck RNF31andIRF9.c 1451 to 1601 11 to 159       149/159
(93 %)
6 diff
(96.3 %id)
BE728713 melanotic melanoma, skin RNF31andIRF9.c 1510 to 1840 1 to 332       332/718
(46 %)
3 diff
(99.6 %id)
CR994428 T-Lymphocytes RNF31andIRF9.c 2291 to 3168 1 to 881       881/882
(99 %)
7 diff
(99.3 %id)
TI_1948140121   RNF31andIRF9.c 2294 to 3111 940 to 110       831/1302
(63 %)
37 diff
(97.2 %id)
BM696953 eye, lens RNF31andIRF9.c 2327 to 2787 1 to 461   fully sequenced,   461/461
(100 %)
0 diff
(100 %id)
BQ101155 Islets of Langerhans, Pancreas RNF31andIRF9.c 2336 to 2823 1 to 488   fully sequenced,   488/488
(100 %)
2 diff
(99.6 %id)
TI_149313593   RNF31andIRF9.c 2384 to 3193 894 to 89   AAA   806/968
(83 %)
13 diff
(98.7 %id)
TI_1948139365   RNF31andIRF9.c 2411 to 3111 835 to 132       704/1347
(52 %)
12 diff
(99.2 %id)
TI_149298398   RNF31andIRF9.c 2434 to 3193 835 to 80   AAA   756/799
(94 %)
17 diff
(97.9 %id)
BU633631 cell lines, Chondrosarcoma RNF31andIRF9.c 2487 to 3193 725 to 19   AAA   707/707
(100 %)
0 diff
(100 %id)
BU783848 insulinoma, Pancreas RNF31andIRF9.c 2741 to 3169 429 to 1       429/429
(100 %)
1 diff
(99.8 %id)
BQ100853 Islets of Langerhans, Pancreas RNF31andIRF9.c 2762 to 3194 435 to 3   fully sequenced,   433/435
(99 %)
1 diff
(99.8 %id)
BM667985 eye, lens RNF31andIRF9.c 2774 to 3193 438 to 19   fully sequenced, AAA   420/420
(100 %)
0 diff
(100 %id)
DB293177   RNF31andIRF9.d 1 to 814 2 to 809   tiling clone, capped   808/873
(92 %)
14 diff
(98.4 %id)
DA577768   RNF31andIRF9.d 2 to 566 2 to 566   tiling clone, capped   565/565
(100 %)
1 diff
(99.9 %id)
DA995011 synovial membrane tissue from rheumatioidarthritis RNF31andIRF9.d 2 to 554 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DB147846 thymus RNF31andIRF9.d 12 to 576 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
CB126210 Liver RNF31andIRF9.d 143 to 748 1 to 606   tiling clone,   606/606
(100 %)
0 diff
(100 %id)
DA639610 Liver RNF31andIRF9.d 162 to 713 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
DA412566 thalamus RNF31andIRF9.d 190 to 728 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
AW847145 colon RNF31andIRF9.d 503 to 864 401 to 39   tiling clone,   363/401
(90 %)
5 diff
(98.8 %id)
BG896494 cartilage RNF31andIRF9.d 553 to 841 83 to 371   tiling clone,   289/303
(95 %)
6 diff
(98.1 %id)
AU159573   RNF31andIRF9.d 2694 to 3185 493 to 1   tiling clone,   493/495
(99 %)
8 diff
(98.4 %id)
AK074144 Spleen RNF31andIRF9.e 1 to 4798 1 to 4799 exact tiling clone, available from FLJ,   4799/4799
(100 %)
7 diff
(99.9 %id)
BF529654 anaplastic oligodendroglioma with 1p/19qloss, brain RNF31andIRF9.e 57 to 658 1 to 604       604/604
(100 %)
3 diff
(99.6 %id)
BQ067946 brain RNF31andIRF9.e 63 to 918 15 to 876       862/1070
(80 %)
15 diff
(98.6 %id)
BQ052968 blood, natural killer cells, cell line RNF31andIRF9.e 136 to 1041 1 to 911       911/1049
(86 %)
29 diff
(97.3 %id)
BE730989 choriocarcinoma, placenta RNF31andIRF9.e 152 to 901 1 to 743       743/969
(76 %)
16 diff
(98.4 %id)
CK819439 Islets of Langerhans, Pancreas RNF31andIRF9.e 159 to 739 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BM129043 Islets of Langerhans, Pancreas RNF31andIRF9.e 175 to 753 1 to 579       579/579
(100 %)
1 diff
(99.9 %id)
BQ695405 adipose RNF31andIRF9.e 186 to 435 1 to 250       250/250
(100 %)
0 diff
(100 %id)
BX388812   RNF31andIRF9.e 230 to 993 752 to 1       752/785
(95 %)
12 diff
(98.5 %id)
BM928650 hepatocellular carcinoma, cell line, Liver RNF31andIRF9.e 337 to 1033 1 to 700       700/1037
(67 %)
14 diff
(98.7 %id)
BQ645131 hepatocellular carcinoma, cell line, Liver RNF31andIRF9.e 337 to 1156 1 to 825       825/920
(89 %)
12 diff
(98.7 %id)
BQ645370 hepatocellular carcinoma, cell line, Liver RNF31andIRF9.e 337 to 1164 1 to 834       834/895
(93 %)
13 diff
(98.6 %id)
BG823316 adenocarcinoma cell line, colon RNF31andIRF9.e 338 to 1264 1 to 928       928/928
(100 %)
23 diff
(97.6 %id)
BX372188   RNF31andIRF9.e 346 to 1063 728 to 10       719/907
(79 %)
14 diff
(98.5 %id)
BQ925363 sciatic nerve RNF31andIRF9.e 361 to 1067 1 to 708       708/951
(74 %)
5 diff
(99.5 %id)
CV571427 cornea, eye RNF31andIRF9.e 561 to 1169 1 to 609       609/609
(100 %)
0 diff
(100 %id)
BG251120 adenocarcinoma, cell line, Liver RNF31andIRF9.e 562 to 1275 1 to 711       711/944
(75 %)
12 diff
(98.8 %id)
BX459479 brain, fetal brain RNF31andIRF9.e 618 to 1692 1061 to 1       1061/1074
(98 %)
24 diff
(97.8 %id)
BI860198 breast, mammary adenocarcinoma, cell line RNF31andIRF9.e 662 to 1319 1 to 656       656/656
(100 %)
2 diff
(99.7 %id)
BE075567 breast RNF31andIRF9.e 668 to 1100 432 to 1     Submitted on the opposite strand 432/432
(100 %)
8 diff
(98.2 %id)
BQ934516 sciatic nerve RNF31andIRF9.e 669 to 1395 1 to 735       735/944
(77 %)
22 diff
(97.7 %id)
BE544069 cervical carcinoma cell line, cervix RNF31andIRF9.e 713 to 1422 1 to 702       702/763
(92 %)
18 diff
(97.7 %id)
BX341832   RNF31andIRF9.e 739 to 1675 926 to 1       929/1047
(88 %)
14 diff
(98.7 %id)
BG032479 breast, mammary adenocarcinoma, cell line RNF31andIRF9.e 751 to 1419 1 to 666       666/947
(70 %)
7 diff
(99.3 %id)
BI194918 brain, neuroblastoma RNF31andIRF9.e 792 to 1508 1 to 716       716/716
(100 %)
1 diff
(99.9 %id)
BG697462 skin RNF31andIRF9.e 828 to 1564 1 to 732       732/739
(99 %)
7 diff
(99.1 %id)
BE392301 endometrium, adenocarcinoma cell line, uterus RNF31andIRF9.e 1056 to 1537 1 to 480       480/480
(100 %)
2 diff
(99.6 %id)
AW608305 leiomios RNF31andIRF9.e 1109 to 1696 624 to 28       557/624
(89 %)
23 diff
(96.4 %id)
BM826910 Ascites, stomach RNF31andIRF9.e 1159 to 1579 1 to 421       421/421
(100 %)
0 diff
(100 %id)
AW800271 uterus RNF31andIRF9.e 1359 to 1565 220 to 14       207/233
(88 %)
5 diff
(97.9 %id)
FN056128 breast carcinoma RNF31andIRF9.e 1396 to 1485 90 to 1     Submitted on the opposite strand 90/90
(100 %)
1 diff
(98.9 %id)
BX488086   RNF31andIRF9.e 1581 to 2225 7 to 652   tiling clone,   646/652
(99 %)
6 diff
(99.1 %id)
DA142023 alzheimer cortex RNF31andIRF9.e 2272 to 2815 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
NM_006084.4   RNF31andIRF9.e 2284 to 3959 1 to 1676   RefSeq, AAA   1676/1676
(100 %)
0 diff
(100 %id)
CD722080 eye, lacrimal gland RNF31andIRF9.e 2284 to 2876 1 to 593       593/593
(100 %)
0 diff
(100 %id)
DB165546 thymus RNF31andIRF9.e 2287 to 2879 2 to 594   capped   593/593
(100 %)
2 diff
(99.7 %id)
BI914493 brain RNF31andIRF9.e 2297 to 2980 1 to 686       686/686
(100 %)
2 diff
(99.8 %id)
DB157681 thymus RNF31andIRF9.e 2327 to 2929 2 to 604   capped   603/606
(99 %)
1 diff
(99.9 %id)
DA677007   RNF31andIRF9.e 2337 to 2908 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA257657 caudate nucleus RNF31andIRF9.e 2338 to 2832 2 to 496   capped   495/495
(100 %)
0 diff
(100 %id)
DB141093 thymus RNF31andIRF9.e 2338 to 2832 2 to 496   capped   495/497
(99 %)
1 diff
(99.8 %id)
DA118191 cerebellum RNF31andIRF9.e 2339 to 2888 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
CT000302 T-Lymphocytes RNF31andIRF9.e 2346 to 3086 1 to 741       741/741
(100 %)
0 diff
(100 %id)
BQ722748 dorsal root ganglia RNF31andIRF9.e 2347 to 3281 1 to 949       949/949
(100 %)
28 diff
(97.1 %id)
TI_154188204   RNF31andIRF9.e 2349 to 3174 122 to 944       823/920
(89 %)
35 diff
(96.2 %id)
BX397492 Placenta Cot 25-normalized RNF31andIRF9.e 2354 to 3327 1 to 948       948/967
(98 %)
40 diff
(95.9 %id)
AW403448 lymph RNF31andIRF9.e 2354 to 2773 1 to 420       420/420
(100 %)
5 diff
(98.9 %id)
BM925563 brain RNF31andIRF9.e 2354 to 3266 19 to 941       923/1072
(86 %)
21 diff
(98.1 %id)
DA671867   RNF31andIRF9.e 2354 to 2943 2 to 590   capped   589/589
(100 %)
1 diff
(99.9 %id)
DB001262 breast, tumor tissue RNF31andIRF9.e 2354 to 2919 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DB129524 thymus RNF31andIRF9.e 2354 to 2892 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
CD171831 testis RNF31andIRF9.e 2356 to 3137 1 to 790       790/795
(99 %)
8 diff
(99.0 %id)
DA431810 colon RNF31andIRF9.e 2360 to 2859 2 to 501   capped   500/500
(100 %)
0 diff
(100 %id)
DA627087 Kidney RNF31andIRF9.e 2360 to 2911 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA015795 adrenal gland RNF31andIRF9.e 2361 to 2916 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA103328 cerebellum RNF31andIRF9.e 2361 to 2899 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
DA937731 Spleen RNF31andIRF9.e 2361 to 2947 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
DA983255 synovial membrane tissue from rheumatioidarthritis RNF31andIRF9.e 2361 to 2918 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DB006614 cervix, tumor tissue RNF31andIRF9.e 2361 to 2929 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DB121691 thymus RNF31andIRF9.e 2361 to 2886 2 to 528   capped   527/527
(100 %)
2 diff
(99.7 %id)
DC407971 thymus RNF31andIRF9.e 2361 to 2889 1 to 530       530/530
(100 %)
2 diff
(99.7 %id)
DB153711 thymus RNF31andIRF9.e 2361 to 2943 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DB284203 uterus RNF31andIRF9.e 2361 to 2905 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA949796 Spleen RNF31andIRF9.e 2362 to 2898 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
DB134002 thymus RNF31andIRF9.e 2362 to 2902 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DB155627 thymus RNF31andIRF9.e 2362 to 2940 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DB165730 thymus RNF31andIRF9.e 2362 to 2930 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DB234608 trachea RNF31andIRF9.e 2362 to 2834 2 to 474   capped   473/473
(100 %)
0 diff
(100 %id)
AU310389 neuroblastoma RNF31andIRF9.e 2363 to 2943 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
CB152690 brain RNF31andIRF9.e 2364 to 2906 1 to 543       543/543
(100 %)
0 diff
(100 %id)
DA044352 bladder RNF31andIRF9.e 2364 to 2931 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
CN397957 embryonic stem cells, DMSO-treated H9 cellline RNF31andIRF9.e 2364 to 3098 1 to 735       735/735
(100 %)
2 diff
(99.8 %id)
DA167654 amygdala RNF31andIRF9.e 2365 to 2939 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA206965 brain RNF31andIRF9.e 2365 to 2927 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA240453 brain RNF31andIRF9.e 2365 to 2886 2 to 523   capped   522/522
(100 %)
0 diff
(100 %id)
DA383201 thalamus RNF31andIRF9.e 2365 to 2917 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
BX112169 parathyroid gland, parathyroid tumor RNF31andIRF9.e 2365 to 3058 1 to 695       695/702
(99 %)
3 diff
(99.6 %id)
DA431463 colon RNF31andIRF9.e 2365 to 2837 2 to 475   capped   474/474
(100 %)
1 diff
(99.8 %id)
DA511930 brain RNF31andIRF9.e 2365 to 2924 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
BQ671816 epidermoid carcinoma, cell line, salivary gland RNF31andIRF9.e 2365 to 3272 15 to 933       919/938
(97 %)
27 diff
(97.2 %id)
DA675071   RNF31andIRF9.e 2365 to 2947 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DA826448 pericardium RNF31andIRF9.e 2365 to 2930 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DA924522 small intestine RNF31andIRF9.e 2365 to 2934 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA951288 Spleen RNF31andIRF9.e 2365 to 2931 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DA985750 synovial membrane tissue from rheumatioidarthritis RNF31andIRF9.e 2365 to 2927 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DB002484 breast, tumor tissue RNF31andIRF9.e 2365 to 2905 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DB007165 cervix, tumor tissue RNF31andIRF9.e 2365 to 2929 2 to 566   capped   565/566
(99 %)
1 diff
(99.9 %id)
DB103737 thymus RNF31andIRF9.e 2365 to 2907 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DB111497 thymus RNF31andIRF9.e 2365 to 2944 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
DB137417 thymus RNF31andIRF9.e 2365 to 2859 2 to 495   capped   494/494
(100 %)
1 diff
(99.8 %id)
DB148695 thymus RNF31andIRF9.e 2365 to 2926 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DB160782 thymus RNF31andIRF9.e 2365 to 2859 2 to 497   capped   496/496
(100 %)
1 diff
(99.8 %id)
DB164838 thymus RNF31andIRF9.e 2365 to 2957 2 to 594   capped   593/593
(100 %)
0 diff
(100 %id)
CR619285 Placenta Cot 25-normalized RNF31andIRF9.e 2367 to 3923 1 to 1557       1557/1557
(100 %)
0 diff
(100 %id)
BX378006 Placenta Cot 25-normalized RNF31andIRF9.e 2367 to 3038 1 to 671   fully sequenced,   671/671
(100 %)
1 diff
(99.9 %id)
DN991735 brain, whole brain RNF31andIRF9.e 2368 to 3001 1 to 634       634/634
(100 %)
5 diff
(99.3 %id)
BM920702 pooled brain, lung, testis RNF31andIRF9.e 2369 to 3277 1 to 918       918/1041
(88 %)
23 diff
(97.8 %id)
BI762406 pooled colon, kidney, stomach RNF31andIRF9.e 2371 to 2995 1 to 625       625/625
(100 %)
2 diff
(99.7 %id)
DA134288 alzheimer cortex RNF31andIRF9.e 2373 to 2920 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
BQ685508 ductal carcinoma, cell line, Pancreas RNF31andIRF9.e 2373 to 3225 1 to 858       858/895
(95 %)
9 diff
(99.0 %id)
CR603020 Placenta Cot 25-normalized RNF31andIRF9.e 2375 to 3955 1 to 1581       1581/1581
(100 %)
0 diff
(100 %id)
CR609755 Placenta Cot 25-normalized RNF31andIRF9.e 2375 to 3929 1 to 1555       1555/1555
(100 %)
0 diff
(100 %id)
BX336003 Placenta Cot 25-normalized RNF31andIRF9.e 2375 to 3085 1 to 710       710/710
(100 %)
1 diff
(99.9 %id)
TI_57201093   RNF31andIRF9.e 2376 to 3070 66 to 760       695/760
(91 %)
6 diff
(99.3 %id)
TI_57178898   RNF31andIRF9.e 2376 to 3108 30 to 762       733/762
(96 %)
8 diff
(99.0 %id)
BF530805 anaplastic oligodendroglioma with 1p/19qloss, brain RNF31andIRF9.e 2377 to 3059 1 to 679       679/766
(88 %)
14 diff
(98.2 %id)
BI818281 pooled brain, lung, testis RNF31andIRF9.e 2377 to 3052 1 to 678       678/678
(100 %)
2 diff
(99.8 %id)
BI823840 pooled brain, lung, testis RNF31andIRF9.e 2377 to 3070 1 to 694       694/694
(100 %)
0 diff
(100 %id)
BI772133 pooled lung and spleen RNF31andIRF9.e 2377 to 3108 1 to 732       732/732
(100 %)
2 diff
(99.8 %id)
CB215849 normal endometrium, late proliferativephase, cycle day 13, uterus RNF31andIRF9.e 2377 to 2995 1 to 619       619/619
(100 %)
0 diff
(100 %id)
BM905847 leiomyosarcoma, uterus RNF31andIRF9.e 2378 to 3373 1 to 1000       1000/1000
(100 %)
13 diff
(98.7 %id)
BM545567 brain, hippocampus RNF31andIRF9.e 2378 to 3143 1 to 775       775/1016
(76 %)
22 diff
(97.9 %id)
BM548311 brain, hippocampus RNF31andIRF9.e 2378 to 3020 20 to 662       643/1149
(55 %)
13 diff
(98.9 %id)
BM450172 melanotic melanoma, skin RNF31andIRF9.e 2383 to 3344 1 to 978       978/1015
(96 %)
33 diff
(96.8 %id)
BI768972 pooled lung and spleen RNF31andIRF9.e 2384 to 3283 1 to 887       887/920
(96 %)
31 diff
(96.7 %id)
TI_57181792   RNF31andIRF9.e 2384 to 3283 34 to 920       887/953
(93 %)
37 diff
(96.2 %id)
BF973844 leiomyosarcoma cell line, uterus RNF31andIRF9.e 2385 to 3188 1 to 805       804/875
(91 %)
30 diff
(96.6 %id)
TI_57215641   RNF31andIRF9.e 2385 to 3305 35 to 952       918/963
(95 %)
25 diff
(97.5 %id)
BI753949 brain RNF31andIRF9.e 2386 to 3305 1 to 917       917/928
(98 %)
19 diff
(98.0 %id)
M87503   RNF31andIRF9.e 2386 to 3948 10 to 1573       1564/1584
(98 %)
10 diff
(99.4 %id)
DA368122 subthalamic nucleus RNF31andIRF9.e 2389 to 2970 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
BM546021 ovary (pool of 3) RNF31andIRF9.e 2390 to 3400 22 to 1037       1016/1121
(90 %)
54 diff
(95.2 %id)
DR155352 human embryonic stem cells differentiated toan early endodermal cell type RNF31andIRF9.e 2391 to 3189 1 to 799       799/799
(100 %)
0 diff
(100 %id)
BM763536 myeloma RNF31andIRF9.e 2391 to 2834 1 to 444       444/444
(100 %)
0 diff
(100 %id)
BM782298 myeloma RNF31andIRF9.e 2391 to 3025 1 to 635       635/635
(100 %)
0 diff
(100 %id)
DA018080 adrenal gland RNF31andIRF9.e 2392 to 2941 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA291534 hippocampus RNF31andIRF9.e 2392 to 2952 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA308412 hippocampus RNF31andIRF9.e 2392 to 2951 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
BI755721 brain RNF31andIRF9.e 2399 to 3326 1 to 929       929/932
(99 %)
19 diff
(98.0 %id)
BI837938 pooled pancreas and spleen RNF31andIRF9.e 2399 to 3108 1 to 715       713/718
(99 %)
12 diff
(98.4 %id)
BI833940 pooled pancreas and spleen RNF31andIRF9.e 2399 to 3167 1 to 772       772/956
(80 %)
19 diff
(98.1 %id)
CN397953 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 RNF31andIRF9.e 2401 to 2897 1 to 497       497/497
(100 %)
1 diff
(99.8 %id)
BM913576 amelanotic melanoma, cell line, skin RNF31andIRF9.e 2402 to 3113 1 to 714       714/1112
(64 %)
8 diff
(99.3 %id)
BU195806 leiomyosarcoma, uterus RNF31andIRF9.e 2404 to 3303 1 to 904       904/904
(100 %)
18 diff
(98.1 %id)
CB216083 normal endometrium, mid-secretory phase,cycle day 23, uterus RNF31andIRF9.e 2405 to 2947 1 to 543       543/543
(100 %)
0 diff
(100 %id)
CR985849 T-Lymphocytes RNF31andIRF9.e 2405 to 3154 1 to 752       752/752
(100 %)
3 diff
(99.7 %id)
CR596057 Placenta Cot 25-normalized RNF31andIRF9.e 2407 to 3931 1 to 1525       1525/1525
(100 %)
0 diff
(100 %id)
CR602478 Placenta Cot 25-normalized RNF31andIRF9.e 2407 to 3922 1 to 1516       1516/1516
(100 %)
0 diff
(100 %id)
CR610511 thymus RNF31andIRF9.e 2407 to 3928 1 to 1522       1522/1522
(100 %)
0 diff
(100 %id)
BX436621 thymus RNF31andIRF9.e 2407 to 3038 1 to 633   fully sequenced,   633/633
(100 %)
3 diff
(99.6 %id)
BX336161 Placenta Cot 25-normalized RNF31andIRF9.e 2407 to 3229 1 to 826       826/826
(100 %)
16 diff
(98.1 %id)
BX397505 Placenta Cot 25-normalized RNF31andIRF9.e 2407 to 3374 1 to 961       961/971
(98 %)
13 diff
(98.7 %id)
BM906740 ovary (pool of 3) RNF31andIRF9.e 2407 to 3271 25 to 898       874/1124
(77 %)
31 diff
(97.3 %id)
TI_57217140   RNF31andIRF9.e 2407 to 3326 43 to 963       921/966
(95 %)
24 diff
(97.6 %id)
TI_57163381   RNF31andIRF9.e 2407 to 3108 39 to 745       705/748
(94 %)
17 diff
(97.8 %id)
TI_57164413   RNF31andIRF9.e 2407 to 3151 46 to 793       748/993
(75 %)
18 diff
(98.2 %id)
BC035716 Ovary, pooled from 3 adults RNF31andIRF9.e 2408 to 3960 1 to 1553   available from MGC, AAA   1553/1553
(100 %)
2 diff
(99.9 %id)
EL734321 mixed RNF31andIRF9.e 2411 to 3073 1 to 663       663/663
(100 %)
7 diff
(99.0 %id)
TI_1948209587   RNF31andIRF9.e 2411 to 3059 131 to 779   fully sequenced,   649/779
(83 %)
7 diff
(99.2 %id)
BX388740 Placenta Cot 25-normalized RNF31andIRF9.e 2419 to 3291 873 to 1       871/873
(99 %)
12 diff
(98.7 %id)
BE887127 leiomyosarcoma, uterus RNF31andIRF9.e 2442 to 3188 1 to 743       743/779
(95 %)
12 diff
(98.5 %id)
BQ054110 blood, natural killer cells, cell line RNF31andIRF9.e 2454 to 3394 26 to 979       954/1084
(88 %)
32 diff
(97.1 %id)
DN994405 brain, whole brain RNF31andIRF9.e 2479 to 3025 1 to 547       547/547
(100 %)
5 diff
(99.1 %id)
CF272501 Brain glioblastoma RNF31andIRF9.e 2488 to 3365 1 to 884       884/893
(98 %)
12 diff
(98.7 %id)
BG696140 skin RNF31andIRF9.e 2497 to 3241 1 to 755       755/854
(88 %)
25 diff
(97.1 %id)
TI_154188163   RNF31andIRF9.e 2510 to 3404 121 to 1003       883/942
(93 %)
30 diff
(96.9 %id)
BM561005 amelanotic melanoma, cell line, skin RNF31andIRF9.e 2526 to 3400 1 to 882       882/1049
(84 %)
17 diff
(98.4 %id)
TI_59387607   RNF31andIRF9.e 2526 to 3290 99 to 868       770/820
(93 %)
22 diff
(97.4 %id)
BM017355 astrocytoma grade IV, cell line, brain RNF31andIRF9.e 2527 to 3290 1 to 769       769/819
(93 %)
22 diff
(97.4 %id)
FN046383 breast carcinoma RNF31andIRF9.e 2532 to 2592 1 to 61       61/61
(100 %)
0 diff
(100 %id)
BI030861 marrow RNF31andIRF9.e 2576 to 2961 386 to 1       386/386
(100 %)
6 diff
(98.5 %id)
BX347133 Placenta Cot 25-normalized RNF31andIRF9.e 2602 to 3462 858 to 1       858/858
(100 %)
5 diff
(99.5 %id)
BX477441   RNF31andIRF9.e 2618 to 3162 1 to 545       545/547
(99 %)
1 diff
(99.9 %id)
BX388586 Placenta Cot 25-normalized RNF31andIRF9.e 2621 to 3407 1 to 794       794/856
(92 %)
20 diff
(97.7 %id)
BI047862 stomach RNF31andIRF9.e 2672 to 2861 191 to 2       190/191
(99 %)
1 diff
(99.5 %id)
BF340236 brain, glioblastoma with EGFR amplification RNF31andIRF9.e 2697 to 3394 1 to 696       696/697
(99 %)
3 diff
(99.6 %id)
AV652034 corresponding non cancerous liver tissue RNF31andIRF9.e 2755 to 3468 1 to 714     Submitted on the opposite strand 714/716
(99 %)
15 diff
(98.0 %id)
BX326295 Placenta Cot 25-normalized RNF31andIRF9.e 2789 to 3704 1 to 915       915/915
(100 %)
11 diff
(98.8 %id)
G64280   RNF31andIRF9.e 2832 to 3068 1 to 237       237/237
(100 %)
0 diff
(100 %id)
TI_159678270   RNF31andIRF9.e 2860 to 3535 708 to 33       676/1078
(62 %)
2 diff
(99.9 %id)
CA305900 Alveolar Macrophage, lung RNF31andIRF9.e 2928 to 3664 751 to 17   AAA   735/735
(100 %)
2 diff
(99.8 %id)
BX339134 Placenta Cot 25-normalized RNF31andIRF9.e 2939 to 3931 992 to 1       992/992
(100 %)
18 diff
(98.2 %id)
BX389513 Placenta Cot 25-normalized RNF31andIRF9.e 2945 to 3796 26 to 866       841/901
(93 %)
29 diff
(96.8 %id)
BF525953 brain, glioblastoma with EGFR amplification RNF31andIRF9.e 2955 to 3738 1 to 782       782/1120
(69 %)
25 diff
(97.8 %id)
BQ675759 epidermoid carcinoma, cell line, salivary gland RNF31andIRF9.e 2958 to 3694 24 to 766       743/979
(75 %)
23 diff
(97.7 %id)
BX325914 Placenta Cot 25-normalized RNF31andIRF9.e 2986 to 3818 1 to 830       830/836
(99 %)
16 diff
(98.1 %id)
BX325892 Placenta Cot 25-normalized RNF31andIRF9.e 3001 to 3834 1 to 834       834/835
(99 %)
3 diff
(99.7 %id)
BX388625 Placenta Cot 25-normalized RNF31andIRF9.e 3005 to 3874 1 to 880       880/885
(99 %)
23 diff
(97.5 %id)
BX436620 thymus RNF31andIRF9.e 3008 to 3928 920 to 1   fully sequenced,   920/920
(100 %)
8 diff
(99.2 %id)
BX378005 Placenta Cot 25-normalized RNF31andIRF9.e 3008 to 3919 913 to 4   fully sequenced,   910/913
(99 %)
1 diff
(99.9 %id)
BX346936 Placenta Cot 25-normalized RNF31andIRF9.e 3008 to 3877 1 to 864       864/864
(100 %)
26 diff
(97.0 %id)
BX325994 Placenta Cot 25-normalized RNF31andIRF9.e 3017 to 3877 1 to 854       854/855
(99 %)
51 diff
(94.1 %id)
TI_1948209588   RNF31andIRF9.e 3029 to 3591 687 to 128   fully sequenced,   560/687
(81 %)
2 diff
(99.8 %id)
BU784065 insulinoma, Pancreas RNF31andIRF9.e 3054 to 3642 1 to 589       589/589
(100 %)
5 diff
(99.2 %id)
BQ073782 epidermoid carcinoma, cell line, lung RNF31andIRF9.e 3055 to 3959 933 to 13   AAA Submitted on the opposite strand 921/1016
(90 %)
30 diff
(97.1 %id)
BX336160 Placenta Cot 25-normalized RNF31andIRF9.e 3056 to 3931 876 to 1       876/876
(100 %)
23 diff
(97.4 %id)
AA837561 epithelium (cell line), Prostate RNF31andIRF9.e 3056 to 3666 607 to 1       607/607
(100 %)
11 diff
(98.2 %id)
BX346881 Placenta Cot 25-normalized RNF31andIRF9.e 3089 to 3915 1 to 838       838/888
(94 %)
24 diff
(97.3 %id)
BM708088 eye, RPE and Choroid RNF31andIRF9.e 3106 to 3432 1 to 327   fully sequenced,   327/327
(100 %)
0 diff
(100 %id)
BX392567 Placenta Cot 25-normalized RNF31andIRF9.e 3108 to 3955 846 to 1       846/864
(97 %)
44 diff
(95.0 %id)
CN397956 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 RNF31andIRF9.e 3122 to 3228 1 to 107       107/107
(100 %)
0 diff
(100 %id)
BX369332 Placenta Cot 25-normalized RNF31andIRF9.e 3194 to 3959 1 to 767       767/767
(100 %)
10 diff
(98.7 %id)
AI026930   RNF31andIRF9.e 3200 to 3961 765 to 2       764/765
(99 %)
11 diff
(98.6 %id)
BF957805 nervous_normal RNF31andIRF9.e 3203 to 3726 530 to 6       525/530
(99 %)
1 diff
(99.9 %id)
BX373125 Placenta Cot 25-normalized RNF31andIRF9.e 3233 to 3957 731 to 1       731/868
(84 %)
27 diff
(96.9 %id)
CD366276 Alveolar Macrophage, lung RNF31andIRF9.e 3241 to 3958 735 to 19   AAA   717/720
(99 %)
1 diff
(99.9 %id)
TI_154105221   RNF31andIRF9.e 3245 to 3959 795 to 81   AAA   715/716
(99 %)
3 diff
(99.6 %id)
BQ574532 Chondrosarcoma Grade II, Left Pelvis RNF31andIRF9.e 3266 to 3959 712 to 19   AAA   694/694
(100 %)
0 diff
(100 %id)
TI_154132744   RNF31andIRF9.e 3292 to 3961 795 to 123       673/931
(72 %)
13 diff
(98.7 %id)
AI922741 adenocarcinoma, Pancreas RNF31andIRF9.e 3299 to 3954 655 to 1       655/655
(100 %)
6 diff
(99.1 %id)
CA308170 Alveolar Macrophage, lung RNF31andIRF9.e 3309 to 3959 666 to 16   AAA   651/651
(100 %)
0 diff
(100 %id)
BX326268 Placenta Cot 25-normalized RNF31andIRF9.e 3317 to 3961 1 to 650       650/653
(99 %)
8 diff
(98.8 %id)
CA446496 Chondrosarcoma, Left Pubic Bone RNF31andIRF9.e 3322 to 3959 656 to 19   AAA   638/638
(100 %)
0 diff
(100 %id)
TI_154137171   RNF31andIRF9.e 3358 to 3959 681 to 85   AAA   597/865
(69 %)
12 diff
(98.7 %id)
BU731942 eye, RPE and Choroid RNF31andIRF9.e 3371 to 3959 607 to 19   fully sequenced, AAA   589/589
(100 %)
3 diff
(99.5 %id)
BM998231 lung, Metastatic Chondrosarcoma RNF31andIRF9.e 3396 to 3958 581 to 19   AAA   563/563
(100 %)
2 diff
(99.7 %id)
AI813985 adenocarcinoma, Pancreas RNF31andIRF9.e 3400 to 3959 560 to 1       560/560
(100 %)
5 diff
(99.2 %id)
BU628284 Bone, Enchondroma cell line RNF31andIRF9.e 3405 to 3959 573 to 19   AAA   555/555
(100 %)
1 diff
(99.9 %id)
BQ002133 Chondrosarcoma, Left Pelvis RNF31andIRF9.e 3407 to 3958 567 to 17   AAA   551/551
(100 %)
2 diff
(99.7 %id)
AW238276 carcinoma in situ from retromolar trigone RNF31andIRF9.e 3424 to 3959 9 to 546     Submitted on the opposite strand 538/546
(98 %)
5 diff
(99.1 %id)
AW864163 stomach_normal RNF31andIRF9.e 3436 to 3831 400 to 3       398/414
(96 %)
3 diff
(99.3 %id)
DB309232 hippocampus RNF31andIRF9.e 3437 to 3952 518 to 1       518/518
(100 %)
7 diff
(98.7 %id)
AW575286 lymph RNF31andIRF9.e 3437 to 3959 540 to 18   AAA   523/523
(100 %)
3 diff
(99.5 %id)
AU310390 neuroblastoma RNF31andIRF9.e 3447 to 3959 545 to 32   AAA   514/514
(100 %)
1 diff
(99.9 %id)
BP392894 pancreatic islet RNF31andIRF9.e 3456 to 3958 1 to 503     Submitted on the opposite strand 503/503
(100 %)
0 diff
(100 %id)
AW961244   RNF31andIRF9.e 3482 to 3962 1 to 480   tiling clone,   480/486
(98 %)
1 diff
(99.8 %id)
AA833826 germinal center B cell RNF31andIRF9.e 3493 to 3961 498 to 30       469/498
(94 %)
2 diff
(99.6 %id)
FN081325 breast carcinoma RNF31andIRF9.e 3671 to 3771 103 to 5     Submitted on the opposite strand 99/103
(96 %)
0 diff
(100 %id)
DA934735 Spleen RNF31andIRF9.e 3786 to 4363 2 to 580   capped   579/579
(100 %)
2 diff
(99.7 %id)
FN123155 breast carcinoma RNF31andIRF9.e 3803 to 3925 127 to 1     Submitted on the opposite strand 127/127
(100 %)
4 diff
(96.9 %id)
BQ706149 Spleen RNF31andIRF9.e 4173 to 4798 1 to 626   tiling clone, AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 626/626
(100 %)
7 diff
(98.9 %id)
BQ711267 Spleen RNF31andIRF9.e 4175 to 4798 1 to 624   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 624/624
(100 %)
6 diff
(99.1 %id)
AI204218   RNF31andIRF9.f 1 to 417 5 to 420   tiling clone, Submitted on the opposite strand 420/420
(100 %)
4 diff
(99.1 %id)
AK027154 Human lung RNF31andIRF9.f 49 to 1990 1 to 1945 H392R Y472N A485S Y488D V503S ... tiling clone, available from FLJ, AAA   1945/1945
(100 %)
14 diff
(99.3 %id)
BX505861   RNF31andIRF9.f 93 to 768 1 to 678       678/683
(99 %)
4 diff
(99.5 %id)
BX339135 Placenta Cot 25-normalized RNF31andIRF9.g 1 to 938 7 to 936   tiling clone,   935/939
(99 %)
13 diff
(98.7 %id)
BM769918 stomach RNF31andIRF9.g 912 to 1433 1 to 522       522/522
(100 %)
0 diff
(100 %id)
BM769792 stomach RNF31andIRF9.g 912 to 1518 1 to 607   tiling clone,   607/609
(99 %)
1 diff
(99.9 %id)
BQ083472 stomach RNF31andIRF9.g 912 to 1312 1 to 401       401/401
(100 %)
0 diff
(100 %id)
BM823406 stomach RNF31andIRF9.g 912 to 1426 1 to 516       516/516
(100 %)
15 diff
(97.1 %id)
BM825576 stomach RNF31andIRF9.g 912 to 1403 1 to 492       492/492
(100 %)
0 diff
(100 %id)
BM825698 stomach RNF31andIRF9.g 912 to 1335 1 to 424       424/424
(100 %)
0 diff
(100 %id)
BM826734 stomach RNF31andIRF9.g 912 to 1314 1 to 403       403/403
(100 %)
1 diff
(99.8 %id)
BM831096 stomach RNF31andIRF9.g 912 to 1488 1 to 577       577/577
(100 %)
0 diff
(100 %id)
BM826889 stomach RNF31andIRF9.g 912 to 1163 1 to 252       252/252
(100 %)
2 diff
(99.3 %id)
BQ084121 stomach RNF31andIRF9.g 914 to 1250 1 to 337       337/341
(98 %)
4 diff
(98.9 %id)
BX396242 Placenta Cot 25-normalized RNF31andIRF9.h 1 to 1039 1 to 1037   tiling clone,   1037/1037
(100 %)
4 diff
(99.7 %id)
CN344563 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 RNF31andIRF9.i 1 to 412 108 to 519   tiling clone,   412/519
(79 %)
6 diff
(98.9 %id)
BP376513 uterus RNF31andIRF9.i 382 to 956 1 to 578   tiling clone,   578/578
(100 %)
8 diff
(98.7 %id)
BI912653 leukocyte RNF31andIRF9.j 1 to 824 38 to 860 K26N W27V R28E V29S S31Q ... tiling clone,   831/864
(96 %)
13 diff
(98.5 %id)
TI_57247414   RNF31andIRF9.j 1 to 824 38 to 860 K26N W27V R28E V29S S31Q ...     831/864
(96 %)
13 diff
(98.5 %id)
AK308347 thymus RNF31andIRF9.k 1 to 1009 4 to 1012 E189* tiling clone,   1012/1012
(100 %)
3 diff
(99.8 %id)
BQ883045 dorsal root ganglia RNF31andIRF9.k 1 to 915 3 to 925 D9E S10A L11W D12T S13A ...     925/927
(99 %)
26 diff
(97.2 %id)
CR991252 T-Lymphocytes RNF31andIRF9.k 8 to 847 1 to 841   tiling clone,   841/841
(100 %)
1 diff
(99.9 %id)
TI_57173467   RNF31andIRF9.k 13 to 735 28 to 762       735/763
(96 %)
26 diff
(96.6 %id)
BI826427 brain, medulla RNF31andIRF9.k 14 to 735 1 to 734       734/735
(99 %)
20 diff
(97.3 %id)
AK295467 hippocampus RNF31andIRF9.k 28 to 1766 1 to 1739   tiling clone,   1739/1739
(100 %)
1 diff
(100.0 %id)
BI838150 pooled pancreas and spleen RNF31andIRF9.k 39 to 847 1 to 810       810/812
(99 %)
8 diff
(99.1 %id)
TI_57163285   RNF31andIRF9.k 39 to 847 37 to 846       810/848
(95 %)
8 diff
(99.1 %id)
TI_1948209897   RNF31andIRF9.k 48 to 866 126 to 776       651/1168
(55 %)
8 diff
(99.4 %id)
BF848998 lung_normal RNF31andIRF9.k 333 to 911 596 to 19     Submitted on the opposite strand 578/596
(96 %)
10 diff
(98.4 %id)
CX166488 human embryonic stem cells differentiated toan early endodermal cell type RNF31andIRF9.k 534 to 1269 1 to 736       736/736
(100 %)
1 diff
(99.9 %id)
BQ347253 nervous_tumor RNF31andIRF9.k 594 to 842 263 to 16       248/263
(94 %)
0 diff
(100 %id)
BF857432 prostate_tumor RNF31andIRF9.k 635 to 1109 474 to 2     Submitted on the opposite strand 473/477
(99 %)
0 diff
(100 %id)
BQ720721 sympathetic trunk RNF31andIRF9.k 680 to 1485 45 to 859       815/993
(82 %)
24 diff
(97.6 %id)
BI000990 head_normal RNF31andIRF9.k 723 to 1212 520 to 27       494/528
(93 %)
0 diff
(100 %id)
BM742434 Ascites, stomach RNF31andIRF9.k 795 to 1376 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BM757221 Ascites, stomach RNF31andIRF9.k 795 to 1229 1 to 436       436/436
(100 %)
1 diff
(99.8 %id)
BM765015 Ascites, stomach RNF31andIRF9.k 795 to 1095 1 to 301       301/301
(100 %)
6 diff
(98.1 %id)
BM772575 Ascites, stomach RNF31andIRF9.k 795 to 1365 1 to 572       572/572
(100 %)
2 diff
(99.7 %id)
BM773193 Ascites, stomach RNF31andIRF9.k 795 to 1086 1 to 292       292/292
(100 %)
0 diff
(100 %id)
DA376119 thalamus RNF31andIRF9.k 797 to 1352 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
BP418062 small intestine RNF31andIRF9.k 806 to 1174 1 to 369     Submitted on the opposite strand 369/369
(100 %)
3 diff
(99.2 %id)
BG674505 skin RNF31andIRF9.k 811 to 1589 1 to 781       781/783
(99 %)
6 diff
(99.3 %id)
BQ082889 stomach RNF31andIRF9.k 1019 to 1305 1 to 287       287/287
(100 %)
1 diff
(99.7 %id)
BQ083313 stomach RNF31andIRF9.k 1019 to 1267 1 to 249       249/249
(100 %)
4 diff
(98.4 %id)
TI_1948209898   RNF31andIRF9.k 1165 to 1707 669 to 127       543/1327
(40 %)
4 diff
(99.7 %id)
TI_57216896   RNF31andIRF9.l 1 to 879 32 to 908 P162H S181K R184E G185A L186S ... tiling clone,   877/999
(87 %)
31 diff
(96.9 %id)
BI756532 brain RNF31andIRF9.l 4 to 879 1 to 874 P162H S181K R184E G185A L186S ... tiling clone,   874/965
(90 %)
26 diff
(97.4 %id)
U92994 brain RNF31andIRF9.m 1 to 658 1 to 657 M186W E187S Q188R A189P E200K tiling clone,   657/658
(99 %)
8 diff
(98.8 %id)
DC421058 uterus RNF31andIRF9.n 1 to 583 1 to 583 R3K tiling clone,   583/583
(100 %)
1 diff
(99.9 %id)
BF530066 anaplastic oligodendroglioma with 1p/19qloss, brain RNF31andIRF9.o 1 to 782 1 to 778 exact tiling clone,   778/807
(96 %)
30 diff
(96.3 %id)
CN397955 embryonic stem cells, cell lines H1, H7, andH9 RNF31andIRF9.o 75 to 793 12 to 729       718/729
(98 %)
7 diff
(99.1 %id)
BQ708006 Spleen RNF31andIRF9.o 539 to 1437 1 to 894   tiling clone,   894/923
(96 %)
18 diff
(98.1 %id)
BF360435 marrow RNF31andIRF9.o 1114 to 1389 1 to 276   tiling clone,   276/282
(97 %)
14 diff
(95.1 %id)
CN397958 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells RNF31andIRF9.p 1 to 620 6 to 625 exact tiling clone,   625/625
(100 %)
1 diff
(99.9 %id)
DC411056 thymus RNF31andIRF9.p 1 to 557 5 to 561 exact     561/561
(100 %)
0 diff
(100 %id)
DC410313 thymus RNF31andIRF9.p 1 to 596 4 to 599 exact     599/599
(100 %)
1 diff
(99.9 %id)
DC338718 subthalamic nucleus RNF31andIRF9.p 1 to 548 1 to 548 exact     548/548
(100 %)
0 diff
(100 %id)
CV401231 nervous_normal RNF31andIRF9.p 608 to 1106 21 to 517   tiling clone,   497/543
(91 %)
3 diff
(99.5 %id)
BU507162 leiomyosarcoma, uterus RNF31andIRF9.q 1 to 693 1 to 702 Q138K L151P E152G V153S L154T ... tiling clone,   702/1014
(69 %)
19 diff
(98.2 %id)
BX506052   RNF31andIRF9.r 1 to 730 2 to 731 exact tiling clone,   731/731
(100 %)
0 diff
(100 %id)
DA368051 subthalamic nucleus RNF31andIRF9.r 578 to 1149 2 to 576   tiling clone, capped   575/575
(100 %)
4 diff
(99.4 %id)
CX869269 embryonic stem RNF31andIRF9.r 890 to 1529 1 to 641   tiling clone,   641/641
(100 %)
3 diff
(99.6 %id)
CV571218 cornea, eye RNF31andIRF9.r 1364 to 1953 1 to 590   tiling clone,   590/590
(100 %)
0 diff
(100 %id)
BF871149 lung_tumor RNF31andIRF9.r 1819 to 2199 397 to 17   tiling clone, Submitted on the opposite strand 381/397
(95 %)
0 diff
(100 %id)
AI904989 breast RNF31andIRF9.r 1876 to 2177 304 to 2       303/304
(99 %)
0 diff
(100 %id)
BM693231 eye, Retina Foveal and Macular RNF31andIRF9.r 2145 to 2554 1 to 410   tiling clone,   410/410
(100 %)
0 diff
(100 %id)
BE062305 breast RNF31andIRF9.r 2521 to 2655 160 to 26   tiling clone, Submitted on the opposite strand 135/161
(83 %)
0 diff
(100 %id)
BM668545 eye, Retina Foveal and Macular RNF31andIRF9.r 2621 to 3265 658 to 17   tiling clone, AAA   642/642
(100 %)
3 diff
(99.6 %id)
CX869185 embryonic stem RNF31andIRF9.r 2712 to 3266 592 to 39   AAA   554/554
(100 %)
17 diff
(97.0 %id)
DC400299 testis RNF31andIRF9.s 1 to 543 4 to 546 S10G tiling clone,   546/546
(100 %)
1 diff
(99.9 %id)
DB110041 thymus RNF31andIRF9.t 1 to 578 2 to 579   tiling clone, capped   578/578
(100 %)
1 diff
(99.9 %id)
BF854275 lung_normal RNF31andIRF9.t 81 to 605 526 to 4 D133I F134P Q135E N136L tiling clone, Submitted on the opposite strand 523/527
(99 %)
2 diff
(99.7 %id)
CN344570 embryonic stem cells, DMSO-treated H9 cellline RNF31andIRF9.t 118 to 567 1 to 450       450/450
(100 %)
1 diff
(99.8 %id)
DA818980   RNF31andIRF9.u 1 to 564 4 to 567 exact tiling clone, capped   566/566
(100 %)
1 diff
(99.9 %id)
DB728145 hippocampus RNF31andIRF9.va 1 to 715 1 to 715 exact tiling clone, Submitted on the opposite strand 715/715
(100 %)
7 diff
(99.1 %id)
TI_151804153   RNF31andIRF9.vb 1 to 638 92 to 728 exact tiling clone,   637/1153
(55 %)
5 diff
(99.6 %id)
BU739671 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid RNF31andIRF9.vb 161 to 637 495 to 19 exact tiling clone, AAA   477/477
(100 %)
0 diff
(100 %id)
DA093425 cerebellum RNF31andIRF9.vc 1 to 553 2 to 553 exact tiling clone, capped   552/552
(100 %)
1 diff
(99.9 %id)
DB132447 thymus RNF31andIRF9.vd 1 to 536 2 to 538 exact tiling clone, capped   537/537
(100 %)
2 diff
(99.7 %id)
F37342 pectoral muscle (after mastectomy) RNF31andIRF9.ve 1 to 319 1 to 319 exact tiling clone,   319/319
(100 %)
3 diff
(99.1 %id)
F27391 pectoral muscle (after mastectomy) RNF31andIRF9.ve 77 to 275 1 to 199       199/199
(100 %)
2 diff
(99.0 %id)
DC381961 placenta RNF31andIRF9.vf 1 to 568 1 to 568 exact tiling clone,   568/568
(100 %)
1 diff
(99.9 %id)
BU783544 insulinoma, Pancreas RNF31andIRF9.vf 8 to 473 1 to 466   fully sequenced,   466/466
(100 %)
4 diff
(99.2 %id)
BU787795 insulinoma, Pancreas RNF31andIRF9.vf 8 to 320 1 to 313   fully sequenced,   313/313
(100 %)
4 diff
(98.8 %id)
BU787522 insulinoma, Pancreas RNF31andIRF9.vf 290 to 708 419 to 1   fully sequenced,   419/419
(100 %)
3 diff
(99.3 %id)
AA634013 lung RNF31andIRF9.vf 333 to 632 1 to 303     Submitted on the opposite strand 303/367
(82 %)
4 diff
(99.0 %id)
AA601680 pheochromocytoma RNF31andIRF9.vf 355 to 719 1 to 365   tiling clone, Submitted on the opposite strand 365/365
(100 %)
0 diff
(100 %id)
BU782562 insulinoma, Pancreas RNF31andIRF9.vf 443 to 708 266 to 1   fully sequenced,   266/266
(100 %)
2 diff
(99.3 %id)
DB100668 testis RNF31andIRF9.vg 1 to 573 2 to 575   tiling clone, capped   574/574
(100 %)
1 diff
(99.9 %id)
BM929325 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid RNF31andIRF9.vg 523 to 1243 736 to 16   tiling clone, Submitted on the opposite strand 721/738
(97 %)
6 diff
(99.2 %id)
TI_151759897   RNF31andIRF9.vg 523 to 1241 52 to 769   tiling clone, Submitted on the opposite strand 718/994
(72 %)
8 diff
(99.2 %id)
AW836353 leiomios RNF31andIRF9.vg 959 to 1351 1 to 393       393/393
(100 %)
7 diff
(98.3 %id)
DB291512 uterus RNF31andIRF9.vg 1187 to 1663 2 to 478   tiling clone, capped   477/477
(100 %)
0 diff
(100 %id)
DA236907 brain RNF31andIRF9.vh-u 1 to 543 2 to 544   tiling clone, capped   543/543
(100 %)
0 diff
(100 %id)
DB157989 thymus RNF31andIRF9.vh-u 303 to 877 2 to 576 exact tiling clone, capped   575/575
(100 %)
0 diff
(100 %id)
DA587856 lung RNF31andIRF9.vi 1 to 575 2 to 576   tiling clone, capped   575/575
(100 %)
0 diff
(100 %id)
BM050368 eye, normal pigmented retinal epithelium RNF31andIRF9.vi 13 to 749 1 to 737 T97N A101G tiling clone,   737/737
(100 %)
5 diff
(99.4 %id)
BG752239 eye, normal pigmented retinal epithelium RNF31andIRF9.vi 14 to 649 2 to 645   tiling clone,   644/900
(71 %)
22 diff
(97.6 %id)
DB073055 testis RNF31andIRF9.vi 17 to 571 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DA323444 hippocampus RNF31andIRF9.vj-u 1 to 644 2 to 646 L53F R54E Q55T S56E A58C ... tiling clone, capped   645/645
(100 %)
3 diff
(99.6 %id)
DA994990 synovial membrane tissue from rheumatioidarthritis RNF31andIRF9.vk 1 to 558 2 to 564   tiling clone, capped   563/563
(100 %)
6 diff
(99.0 %id)
DA462121 tongue, tumor tissue RNF31andIRF9.vl 1 to 437 2 to 438   capped   437/441
(99 %)
1 diff
(99.8 %id)
DB089294 testis RNF31andIRF9.vl 1 to 556 2 to 557   tiling clone, capped   556/556
(100 %)
0 diff
(100 %id)
DA741952   RNF31andIRF9.vm 1 to 552 2 to 553   tiling clone, capped   552/552
(100 %)
1 diff
(99.9 %id)
DB136410 thymus RNF31andIRF9.vm 3 to 529 2 to 529   capped   528/528
(100 %)
2 diff
(99.7 %id)
DA461446 tongue, tumor tissue RNF31andIRF9.vn 1 to 549 2 to 550 exact tiling clone, capped   549/549
(100 %)
1 diff
(99.9 %id)
109 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve, .vf, .vg, .vh-u, .vi, .vj-u, .vk, .vl, .vm, .vn Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI